This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (236) Neurology and Neurosciences (117) Safety and Error Prevention in Health (160) Wearable Devices and Sensors (678)

Published on in Vol 10 , No 10 (2021) :October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Authors of this article:

Fatima Jamali 1 Author Orcid Image ;   Mayis Aldughmi 2 Author Orcid Image ;   Mohammad W Khasawneh 1 Author Orcid Image ;   Said Dahbour 3, 4 Author Orcid Image ;   Alaa A Salameh 1 Author Orcid Image ;   Abdalla Awidi 1, 5 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Fatima Jamali   1 , PhD ;   Mayis Aldughmi   2 , PhD ;   Mohammad W Khasawneh   1 , MD ;   Said Dahbour   3, 4 , MD ;   Alaa A Salameh   1 , MSc, PT ;   Abdalla Awidi   1, 5 , MD

1 Cell Therapy Center, University of Jordan, Amman, JO

2 Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman, JO

3 Medical Faculty, University of Jordan, Amman, JO

4 Neurology Division, Jordan University Hospital, Amman, JO

5 Hematology Department, Jordan University Hospital, Amman, JO

Corresponding Author: